Table 2 Cardiorespiratory and coagulation management
From: The acute phase management of spinal cord injury affecting polytrauma patients: the ASAP study
Total | |
|---|---|
n (%) | |
MAP target in polytrauma with tSCI | |
60–70 mm Hg | 14 (8.2) |
70–80 mm Hg | 40 (23.4) |
80–90 mm Hg | 84 (49.1) |
90–100 mm Hg | 32 (18.7) |
Other | 1 (0.6) |
Time length of MAP target | |
24 h | 18 (10.5) |
48 h | 26 (15.2) |
72 h | 68 (39.8) |
4 d | 5 (2.9) |
5 d | 17 (9.9) |
6 d | 1 (0.6) |
7 d | 34 (19.9) |
Other | 2 (1.2) |
Reduction in MAP target to achieve bleeding control | |
Yes | 100 (58.5) |
No | 71 (41.5) |
Hb target in polytrauma without tSCI | |
7 g/dL | 61 (35.7) |
8 g/dL | 47 (27.5) |
9 g/dL | 31 (18.1) |
10 g/dL | 31 (18.1) |
Other | 1 (0.6) |
Hb target in case of tSCI | |
Does not change | 125 (73.1) |
Increases | 43 (25.1) |
Decreases | 3 (1.8) |
PaO2 target | |
60–80 mm Hg | 22 (12.9) |
80–100 mm Hg | 94 (55.0) |
100–120 mm Hg | 43 (25.1) |
> 120 mm Hg | 4 (2.3) |
Other | 8 (4.7) |
PaCO2 target | |
< 35 mm Hg | 14 (8.2) |
35–40 mm Hg | 130 (76.0) |
40–45 mm Hg | 19 (11.1) |
> 45 mm Hg | 0 (0.0) |
other | 8 (4.7) |
PLTs count target | |
> 50.000/μL | 59 (34.5) |
> 100.000/μL | 99 (57.9) |
> 250.000/μL | 13 (7.6) |
PT/aPTT target for tSCI Surgery | |
< 1.2 normal control | 81 (47.4) |
< 1.5 normal control | 85 (49.7) |
< 1.8 normal control | 5 (2.9) |
Usefulness of POC test | |
Yes | 109 (63.7) |
No | 62 (36.3) |